
Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Three out of 5 US youths who died by suicide between 2010 and 2021 did not have a documented preceding mental health diagnosis, researchers reported.

Your daily dose of the clinical news you may have missed.

Limiting screen media use to 30 minutes per day or less for all family members improved mental health measures among youth aged 4 to 17 years in this randomized trial.

Data from a study performed during the first season the shot was available expand on clinical trial evidence and support the safety of RSVpreF, authors wrote.

After performing a back blow maneuver on her 10-month-old daughter to dislodge a popcorn kernel, a mother arrives at the ED with the child in distress. What happened?

Your daily dose of the clinical news you may have missed.

The grade B recommendation (moderate certainty) targets youth aged 6 years and older with a BMI at or above the 95th percentile for age and sex.

Among youth aged 10 to 17 years with uncontrolled hyperglycemia dapagliflozin led to a statistically significant reduction in A1c vs placebo in the T2NOW phase 3 clinical trial.

Your daily dose of the clinical news you may have missed.

Despite its limitations for use in other populations, a high BMI proved a very good predictor of dangerous fat mass index in youth aged 8 to 19 years in this study.

Your daily dose of the clinical news you may have missed.

Findings underscore a need for public health initiatives to educate vulnerable populations on cardiometabolic risks, researchers report.

Details on educational gaps, vaccination rates, and the importance of an open dialogue between patients and clinicians, here.

Findings suggest that optimizing care for children with hypertension may reduce the risk of adult CVD, report researchers.

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

The additional indication for benralizumab was supported by data from the phase 3 TATE trial.

The program, when implemented with support of resident training and tangible tools, reduced parent-reported injuries throughout the first 2 years of life.

Measles cases are edging up in the US again as MMR vaccination rates continue to decline. Have parents forgotten the Ohio outbreak of 2022? Have you? Find out, here.

Your daily dose of the clinical news you may have missed.

Findings support current CDC recommendations that all infants should be protected by maternal RSV vaccination or infant receipt of nirsevimab.

Melatonin products, particularly flavored gummies and tablets, were documented in 7 out of 10 ED visits for unsupervised medication exposure in children aged ≤5 years.

AAAAI 2024. Indoor mouse and cockroach, but not cat and dog, allergen exposure were associated with URI outcomes among children with asthma.